Susquehanna International Group
PLRX icon

Susquehanna International Group’s Pliant Therapeutics PLRX Stock Holding History

Susquehanna International Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140K Buy
111,500
+12,000
+12% +$15.2K ﹤0.01% 12080
2025
Q4 		$121K Buy
99,500
+13,200
+15% +$19.8K ﹤0.01% 11343
2025
Q3 		$128K Buy
86,300
+36,600
+74% +$55.8K ﹤0.01% 11407
2025
Q2 		$57.7K Buy
+49,700
New +$70.2K ﹤0.01% 12070
2025
Q1 		– Sell
-108,000
Closed -$1.42M – 13233
2024
Q4 		$1.42M Buy
108,000
+37,800
+54% +$516K ﹤0.01% 6083
2024
Q3 		$787K Buy
70,200
+53,900
+331% +$674K ﹤0.01% 7380
2024
Q2 		$175K Sell
16,300
-21,400
-57% -$276K ﹤0.01% 10531
2024
Q1 		$562K Buy
37,700
+16,100
+75% +$266K ﹤0.01% 8237
2023
Q4 		$391K Sell
21,600
-45,500
-68% -$692K ﹤0.01% 9248
2023
Q3 		$1.16M Buy
67,100
+16,600
+33% +$288K ﹤0.01% 6296
2023
Q2 		$915K Sell
50,500
-52,800
-51% -$1.25M ﹤0.01% 6883
2023
Q1 		$2.75M Buy
103,300
+31,000
+43% +$883K ﹤0.01% 4494
2022
Q4 		$1.4M Buy
72,300
+21,800
+43% +$456K ﹤0.01% 5447
2022
Q3 		$1.05M Sell
50,500
-30,600
-38% -$585K ﹤0.01% 6507
2022
Q2 		$650K Buy
+81,100
New +$519K ﹤0.01% 7627
2022
Q1 		– Sell
-48,500
Closed -$655K – 13747
2021
Q4 		$655K Buy
48,500
+15,200
+46% +$242K ﹤0.01% 8428
2021
Q3 		$562K Buy
+33,300
New +$707K ﹤0.01% 9069

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Susquehanna International Group's PLRX Position: Q1 2026 in Review

Susquehanna International Group increased its Pliant Therapeutics (PLRX) stake by 55% in Q1 2026, buying an estimated $23.7K and bringing the position to 52,956 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12537.

Susquehanna International Group first reported a position in PLRX in Q3 2020 and has held it in 22 quarters since. The position peaked at $15.9M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Susquehanna International Group held 52,956 shares of Pliant Therapeutics worth $66.7K as of Q1 2026.
  • Susquehanna International Group bought 18,755 Pliant Therapeutics shares in Q1 2026, an estimated $23.7K.
  • Pliant Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12537 holding.
  • Susquehanna International Group first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 22 quarters since.
  • Susquehanna International Group's Pliant Therapeutics position peaked at $15.9M in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.